105 related articles for article (PubMed ID: 24985403)
1. Haploidentical T-cell alpha beta receptor and CD19-depleted stem cell transplant for Wiskott-Aldrich syndrome.
Kharya G; Nademi Z; Leahy TR; Dunn J; Barge D; Schulz A; Cant A; Gennery A; Slatter M
J Allergy Clin Immunol; 2014 Nov; 134(5):1199-201. PubMed ID: 24985403
[No Abstract] [Full Text] [Related]
2. Haploidentical Stem Cell Transplantation With TCR Alpha/Beta and CD19 Depletion in a Case of Unstable Hemoglobin Disease.
Kumar K; Badiger S; Damodar S; Bhat S
Transplantation; 2018 Feb; 102(2):e45-e46. PubMed ID: 29084024
[No Abstract] [Full Text] [Related]
3. Haploidentical stem cell transplantation in DOCK8 deficiency - Successful control of pre-existing severe viremia with a TCRaß/CD19-depleted graft and antiviral treatment.
Ghosh S; Schuster FR; Adams O; Babor F; Borkhardt A; Comoli P; Handgretinger R; Lang P; Laws HJ; Siepermann M; Meisel R
Clin Immunol; 2014; 152(1-2):111-4. PubMed ID: 24667686
[No Abstract] [Full Text] [Related]
4. TCRαβ CD19 depletion in allogeneic haematopoietic stem cell transplantation performed for Hurler syndrome.
Mainardi C; Tumino M; Gazzola MV; Rampazzo A; Scarpa M; Messina C
Bone Marrow Transplant; 2016 Mar; 51(3):438-9. PubMed ID: 26551775
[No Abstract] [Full Text] [Related]
5. Successful HLA haploidentical HSCT with post-transplant cyclophosphamide in Wiskott-Aldrich syndrome.
Kreetapirom P; Hongeng S; Manuyakorn W; Anurathapan U; Pakakasama S; Sirachainan N; Andersson BS
Bone Marrow Transplant; 2017 Jun; 52(6):913-914. PubMed ID: 28287640
[No Abstract] [Full Text] [Related]
6. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
7. Generation and flow cytometric quality control of clinical-scale TCRαβ/CD19-depleted grafts.
Bremm M; Cappel C; Erben S; Jarisch A; Schumm M; Arendt A; Bonig H; Klingebiel T; Koehl U; Bader P; Huenecke S
Cytometry B Clin Cytom; 2017 Mar; 92(2):126-135. PubMed ID: 26416332
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources.
Elfeky R; Lazareva A; Qasim W; Veys P
Expert Rev Clin Immunol; 2019 Jul; 15(7):735-751. PubMed ID: 31070946
[No Abstract] [Full Text] [Related]
9. Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.
Locatelli F; Bauquet A; Palumbo G; Moretta F; Bertaina A
Immunol Lett; 2013; 155(1-2):21-3. PubMed ID: 24091162
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.
Lang P; Teltschik HM; Feuchtinger T; Müller I; Pfeiffer M; Schumm M; Ebinger M; Schwarze CP; Gruhn B; Schrauder A; Albert MH; Greil J; Urban C; Handgretinger R
Br J Haematol; 2014 Jun; 165(5):688-98. PubMed ID: 24588540
[TBL] [Abstract][Full Text] [Related]
11. TCR αβ and CD19-depleted haploidentical stem cell transplant with reduced intensity conditioning for Hoyeraal-Hreidarsson syndrome with RTEL1 mutation.
Bhattacharyya R; Tan AM; Chan MY; Jamuar SS; Foo R; Iyer P
Bone Marrow Transplant; 2016 May; 51(5):753-4. PubMed ID: 26808564
[No Abstract] [Full Text] [Related]
12. Unrelated donor BMT for Wiskott-Aldrich syndrome.
Lenarsky C; Weinberg K; Kohn DB; Parkman R
Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
[TBL] [Abstract][Full Text] [Related]
13. Use of two unrelated umbilical cord stem cell units in stem cell transplantation for Wiskott-Aldrich syndrome.
Slatter MA; Bhattacharya A; Flood TJ; Abinun M; Cant AJ; Gennery AR
Pediatr Blood Cancer; 2006 Sep; 47(3):332-4. PubMed ID: 16007596
[TBL] [Abstract][Full Text] [Related]
14. Negative depletion of CD3(+) and TcRαβ(+) T cells.
Handgretinger R
Curr Opin Hematol; 2012 Nov; 19(6):434-9. PubMed ID: 22914586
[TBL] [Abstract][Full Text] [Related]
15. Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome.
Henriquez NV; Rijkers GT; Zegers BJ
J Immunol; 1994 Jul; 153(1):395-9. PubMed ID: 7515927
[TBL] [Abstract][Full Text] [Related]
16. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
Bethge WA; Haegele M; Faul C; Lang P; Schumm M; Bornhauser M; Handgretinger R; Kanz L
Exp Hematol; 2006 Dec; 34(12):1746-52. PubMed ID: 17157172
[TBL] [Abstract][Full Text] [Related]
17. Six-Year Long Follow-up of Patient With Wiskott-Aldrich Syndrome Post Haploidentical Stem Cell Transplant.
Sachdev M; Chakraborty S; Bansal M; Dua V
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1252-e1253. PubMed ID: 33625090
[No Abstract] [Full Text] [Related]
18. Partial depletion of TCR alpha/beta(+)/ CD19(+) cells in matched unrelated transplantation of three patients with osteopetrosis.
Porta F; Cavagnini S; Imberti L; Sottini A; Bolda F; Beghin A; Caruso A; Lanfranchi A
Bone Marrow Transplant; 2015 Dec; 50(12):1583-5. PubMed ID: 26367231
[No Abstract] [Full Text] [Related]
19. Unrelated partially matched peripheral blood stem cell transplantation with highly purified CD34+ cells in a child with Wiskott-Aldrich syndrome.
Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schumm M; Handgretinger R
Bone Marrow Transplant; 2000 Jul; 26(2):235-7. PubMed ID: 10918439
[TBL] [Abstract][Full Text] [Related]
20. Get Outta Here! Addition of Mobilizing Agents to Conditioning Regimen Improves Donor Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome.
Rettig MP
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1309-1311. PubMed ID: 29753160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
